Form 4: HealthEquity Director Rajesh Natarajan Acquires 2,003 Restricted Stock Units

HealthEquity, Inc. Director Rajesh Natarajan has acquired 2,003 restricted stock units, increasing his direct beneficial ownership to 14,277 shares of common stock.

Summary

• Rajesh Natarajan, a Director of HealthEquity, Inc. (HQY), acquired 2,003 shares of common stock in the form of restricted stock units (RSUs).
• The transaction date for this acquisition was June 26, 2025.
• The acquisition price for the restricted stock units was $0, which is typical for equity grants as part of compensation.
• Following this transaction, Rajesh Natarajan directly beneficially owns a total of 14,277 shares of HealthEquity common stock.
• Each restricted stock unit represents a contingent right to receive one share of HealthEquity's common stock.
• The restricted stock units are scheduled to vest in full on the date of HealthEquity's next annual stockholder meeting.
• Vested shares will be delivered to the reporting person upon the earliest of a change of control of the issuer, the reporting person's termination of service, or the reporting person's death, as defined in the issuer's 2024 equity incentive plan.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock units by a director is a positive signal of alignment with shareholder interests, though it is a routine compensation event rather than a direct open market purchase.

Positives

• The acquisition of 2,003 restricted stock units by Director Rajesh Natarajan aligns his interests with those of the company's shareholders.
• The increase in direct beneficial ownership to 14,277 shares demonstrates continued commitment and confidence in HealthEquity's future.

Future Outlook

The acquired restricted stock units are set to vest in full on the date of HealthEquity's next annual stockholder meeting. Vested shares will be delivered upon the earlier of a change of control of the issuer, the reporting person's termination of service, or the reporting person's death, as defined in the issuer's 2024 equity incentive plan.

Industry Context

This Form 4 filing reflects a routine equity grant to a director, a common practice in corporate compensation structures across various industries to align management and director interests with shareholder value.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard compensation practice in publicly traded companies, aligning director incentives with long-term shareholder value.
• The vesting schedule tied to the next annual meeting is also a common structure for such equity grants within the industry.

Related Party Transactions

• The acquisition of 2,003 restricted stock units by Director Rajesh Natarajan is a transaction between the company and a related party (insider) as part of his compensation.

Stakeholder Impact

• Shareholders: The acquisition of restricted stock units by a director generally aligns management's interests with those of shareholders, potentially fostering long-term value creation.

Next Steps

• Vesting of the 2,003 restricted stock units on the date of HealthEquity's next annual stockholder meeting.
• Delivery of vested shares upon the earlier of a change of control, termination of service, or the reporting person's death.

Key Dates

Keywords

HealthEquity, HQY, Rajesh Natarajan, Director, Restricted Stock Units, RSU, Insider Transaction, SEC Form 4, Equity Compensation, Stock Ownership